Peptidoglycan recognition protein 3 and Nod2 synergistically protect mice from dextran sodium sulfate-induced colitis

Journal of Immunology

Volumn 193, Issue 6, 2014, Pages 3055-3069

  Jing, Xuefang ^a   Zulfiqar, Fareeha ^a   Park, Shin Yong ^a   Núñez, Gabriel ^b   Dziarski, Roman ^a   Gupta, Dipika ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE NORTHWEST   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; PEPTIDOGLYCAN RECOGNITION PROTEIN; PEPTIDOGLYCAN RECOGNITION PROTEIN 3; UNCLASSIFIED DRUG; CARD15 PROTEIN, MOUSE; CARRIER PROTEIN; CASPASE 3; DEXTRAN SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EXPERIMENTAL COLITIS; FEMALE; INTESTINAL BLEEDING; INTESTINE EPITHELIUM; INTESTINE FLORA; MOUSE; NONHUMAN; PROTEIN FUNCTION; SURVIVAL TIME; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BONE MARROW CELL; CELL CULTURE; CHEMICALLY INDUCED; COLITIS; DISEASE MODEL; FECES; GENETICS; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; KNOCKOUT MOUSE; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; MICROBIOLOGY; MICROFLORA; PATHOLOGY; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; BONE MARROW CELLS; CARRIER PROTEINS; CASPASE 3; CELL PROLIFERATION; CELLS, CULTURED; COLITIS; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FECES; FEMALE; INFLAMMATION; INTESTINAL MUCOSA; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICROBIOTA; NOD2 SIGNALING ADAPTOR PROTEIN; SIGNAL TRANSDUCTION;

EID: 84907064976     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301548     Document Type: Article

References (72)

1. Macpherson, A. J., and N. L. Harris. 2004. Interactions between commens al intestinal bacteria and the immune system. Nat. Rev. Immunol. 4: 478-485
2. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241
3. Round, J. L., and S. K. Mazmanian. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9: 313-323.
4. Honda K.,D.R. Littman, 2012, The microbiome in infectious disease and inflammation, Annu. Rev. Immunol, 30, 759-795.
5. X avier, R. J., and D. K. Podolsky. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434
6. Sartor, R. B. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577-594
7. Franke, A., D. P. McGovern, J. C. Barrett, K. Wang, G. L. Radford-Smith, T. Ahmad, C. W. Lees, T. Balschun, J. Lee, R. Roberts, et al. 2010. Genomewide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42: 1118-1125
8. McGovern, D. P., A. Gardet, L. Törkvist, P. Goyette, J. Essers, K. D. Taylor, B. M. Neale, R. T. Ong, C. Lagacé , C. Li, et al; NIDDK IBD Genetics Consortium. 2010. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet. 42: 332-337.
9. Anderson, C. A., G. Boucher, C. W. Lees, A. Franke, M. D 'Amato, K. D. Taylor, J. C. Lee, P. Goyette, M. Imielinski, A. Latiano, et al. 2011. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43: 246-252
10. Jostins, L., S. Ripke, R. K. Weersma, R. H. Duerr, D. P. McGovern, K. Y. Hui, J. C. Lee, L. P. Schumm, Y. Sharma, C. A. Anderson, et al; International IBD Genetics Consortium (IIBDGC). 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491: 119-124
11. Royet, J., D. Gupta, and R. Dziarski. 2011. Peptidoglycan recognition pr oteins: modulators of the microbiome and inflammation. Nat. Rev. Immunol. 11: 837-851
12. Kashyap, D. R., M. Wang, L. H. Liu, G. J. Boons, D. Gupta, and R. Dziarski. 2011. Peptidoglycan recognition proteins kill bacteria by activating proteinsensing two-component systems. Nat. Med. 17: 676-683
13. Royet, J., and R. Dziarski. 2007. Peptidoglycan recognition proteins: pleiotropic sensors and effectors of antimicrobial defences. Nat. Rev. Microbiol. 5: 264-277
14. Kang, D., G. Liu, A. Lundström, E. Gelius, and H. Steiner. 1998. A peptidoglycan recognition protein in innate immunity conserved from insects to humans. Proc. Natl. Acad. Sci. USA 95: 10078-10082
15. Liu, C., Z. Xu, D. Gupta, and R. Dziarski. 2001. Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules. J. Biol. Chem. 276: 34686-34694
16. Li, X., S. Wang, H. Wang, and D. Gupta. 2006. Differential expression of peptidoglycan recognition protein 2 in the skin and liver requires different transcription factors. J. Biol. Chem. 281: 20738-20748
17. Lu, X., M. Wang, J. Qi, H. Wang, X. Li, D. Gupta, and R. Dziarski. 2006. Peptidoglycan recognition proteins are a new class of human bactericidal proteins. J. Biol. Chem. 281: 5895-5907
18. Wang, M., L. H. Liu, S. Wang, X. Li, X. Lu, D. Gupta, and R. Dziarski. 2007. Human peptidoglycan recognit ion proteins require zinc to kill both grampositive and gram-negative bacteria and are synergistic with antibacterial peptides. J. Immunol. 178: 3116-3125
19. Kashyap, D. R., A. Rompca, A. Gaballa, J. D. Helmann, J. Chan, C. J. Chang, I. Hozo, D. Gupta, and R. Dziarski. 2014. Peptidoglycan recognition proteins kill bacteria by inducing oxidative, thiol, and metal stress. PLoS Pathog. DOI: 10.1371/journal.ppat.1004280
20. Gelius, E., C. Persson, J. Karlsson, and H. Steiner. 2003. A mammalian peptidoglycan recognition protein with N-acetylmuramoyl-L-alanine amidase activity. Biochem. Biophys. Res. Commun. 306: 988-994
21. Wang, Z. M., X. Li, R. R. Cocklin, M. Wang, M. Wang, K. Fukase, S. Inamura, S. Kusumoto, D. Gupta, and R. Dziarski. 2003. Human peptidoglycan recognition protein-L is an N-acetylmuramoyl-L-alanine amidase. J. Biol. Chem. 278: 49044-49052.
22. Saha, S., X. Jing, S. Y. Park, S. Wang, X. Li, D. Gupta, and R. Dziarski. 2010. Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-g. Cell Host Microbe 8: 147-162
23. Park, S. Y., D. Gupta, R. Hurwich, C. H. Kim, and R. Dziarski. 2011. Peptidoglycan recognition protein Pglyrp2 protects mice from psoriasis-like skin inflammation by promoting regulatory T cells and limiting Th17 responses. J. Immunol. 187: 5813-5823
24. Saha, S., J. Qi, S. Wang, M. Wang, X. Li, Y. G. Kim, G. Nún?ez, D. Gupta, and R. Dziarski. 2009. PGLYRP-2 and Nod2 are both required for peptidoglycaninduced arthritis and local inflammation. Cell Host Microbe 5: 137-150.
25. Park S. Y.,D. Gupta,C. H. Kim,R. Dziarski, 2011, Differential effects of peptidoglycan recognition proteins on experimental atopic and contact dermatitis mediated by Treg and Th17 ells. PLoS ONE, 6, e24961.
26. Park, S. Y., X. Jing, D. Gupta, and R. Dziarski. 2013. Peptidoglycan recognition protein 1 enhances experimental asthma by promoting Th2 and Th17 and limiting regulatory T cell and plasmacytoid dendritic cell responses. J. Immunol. 190: 3480-3492
27. Zulfiqar, F., I. Hozo, S. Rangarajan, R. A. Mariuzza, R. Dziarski, and D. Gupta. 2013. Genetic association of p eptidoglycan recognition protein variants with inflammatory bowel disease. PLoS ONE 8: e67393
28. Ogura, Y., N. Inohara, A. Benito, F. F. Chen, S. Yamaoka, and G. Nunez. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276: 4812-4818
29. Tada, H., S. Aiba, K. Shibata, T. Ohteki, and H. Takada. 2005. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect. Immun. 73: 7967-7976
30. Hisamatsu, T., M. Suzuki, H. C. Reinecker, W. J. Nadeau, B. A. McCormick, and D. K. Podolsky. 2003. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124: 993-1000
31. Akira, S., S . Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801
32. Shaw, M. H., N. Kamada, N. Warner, Y. G. Kim, and G. Nun?ez. 2011. The everexpanding function of NOD2: autophagy, viral recognition, and T cell activation. Trends Immunol. 32: 73-79
33. Franchi, L., N. Warner, K. Viani, and G. Nun? ez. 2009. Function of Nod-like receptors in microbial recognition and host defense. Immunol. Rev. 227: 106-128
34. Girardin, S. E., I. G. Boneca, J. Viala, M. Chamaillard, A. Labigne, G. Thomas, D. J. Philpott, and P. J. Sansonetti. 2 003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278: 8869-8872
35. Inohara, N., Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K. Fukase, S. Inamura, S. Kusumoto, M. Hashimoto, et al. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278: 5509-5512
36. Strober, W., and T. Watanabe. 2011. NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease. Mucosal Immunol. 4: 484-495
37. Hugot, J. P., M. Chamaillard, H. Zouali, S. Lesage, J. P. Cé zard, J. Belaiche, S. Almer, C. Tysk, C. A. O'Morain, M. Gassull, et al. 2001. Association of NOD2 leucine-rich repeat variant s with susceptibility to Crohn's disease. Nature 411: 599-603
38. Ogura, Y., D. K. Bonen, N. Inohara, D. L. Nicolae, F. F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, R. H. Duerr, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606
39. Economou, M., T. A. Trikalinos, K. T. Loizou, E. V. Tsianos, and J. P. Ioannidis. 2004. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am. J. Gastroenterol. 99: 2393-2404
40. van Heel, D. A., S. Ghosh, M. Butler, K. A. Hunt, A. M. Lundberg, T. Ahmad, D. P. McGovern, C. Onnie, K. Negoro, S. Goldthorpe, et al. 2005. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 365: 1794-1796
41. Kobayashi, K. S., M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara, G. Nun?ez, and R. A. Flavell. 2005. Nod2-dependent regulation of innate and adapti ve immunity in the intestinal tract. Science 307: 731-734
42. Watanabe, T., N. Asano, P. J. Murray, K. Ozato, P. Tailor, I. J. Fuss, A. Kitani, and W. Strober. 2008. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J. Clin. Invest. 118: 545-559
43. Couturier-Maillard, A., T. Secher, A. Rehman, S. Normand, A. De Arcang elis, R. Haesler, L. Huot, T. Grandjean, A. Bressenot, A. Delanoye-Crespin, et al. 2013. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 123: 700-711
44. Petnicki-Ocwieja, T., T. Hrncir, Y. J. Liu, A. Biswas, T. Hudcovic, H. Tlaskalova-Hogenova, and K. S. Kobayashi. 2009. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. USA 106: 15813-15818
45. Rehman, A., C. Sina, O. Gavrilova, R. Häsler, S. Ott, J. F. Baines, S. Schreiber, and P. Rosenstiel. 2011. Nod2 is essential for temporal development of intestinal microbial communities. Gut 60: 1354-1362.
46. Mondot S.,F. Barreau,Z. Al Nabhani,M. Dussaillant,K. Le Roux,J. Doré,M. Leclerc,J. P. Hugot,P. Lepage, 2012, Altered gut microbiota composition in immune-impaired Nod2(-/-) mice. Gut, 61, 634-635.
47. Elson, C. O., R. B. Sartor, G. S. Tennyson, and R. H. Riddell. 1995. Experimental models of inflammatory bowel disease. Gastroenterology 109: 1344-1367
48. Kang, S. S., S. M. Bloom, L. A. Norian, M. J. Geske, R. A. Flavell, T. S. Stappenbeck, and P. M. Allen. 2008. An antibiotic-responsive mouse model of fulminant ulcerative colitis. PLoS Med. 5: e41
49. Bloom, S. M., V. N. Bijanki, G. M. Nava, L. Sun, N. P. Malvin, D. L. Donermeyer, W. M. Dunne, Jr., P. M. Allen, and T. S. Stappenbeck. 2011. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9: 390-403
50. Barman, M., D. U nold, K. Shifley, E. Amir, K. Hung, N. Bos, and N. Salzman. 2008. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect. Immun. 76: 907-915
51. Salzman, N. H., K. Hung, D. Haribhai, H. Chu, J. Karlsson-Sjö berg, E. Amir, P. Teggatz, M. Barman, M. Hayward, D. Eastwood, et al. 2010. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11: 76-83
52. Duran-Struuck, R., and R. C. Dysko. 2009. Principles of bone marrow transplantation (BMT): providing optimal veterinary and husbandry care to irradiated mice in BMT studies. J. Am. Assoc. Lab. Anim. Sci. 48: 11-22
53. Denning, T. L., B. A. Norris, O. Medina-Contreras, S. Manicassamy, D. Geem, R. Madan, C. L. Karp, and B. Pulendran. 2011. Fun ctional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization. J. Immunol. 187: 733-747.
54. Atarashi, K., J. Nishimura, T. Shima, Y. Umesaki, M. Yamamoto, M. Onoue, H. Yagita, N. Ishii, R. Evans, K. Honda, and K. Takeda. 2008. ATP drives lamina propria T(H)17 cell different iation. Nature 455: 808-812
55. Grossmann, J., S. Mohr, E. G. Lapentina, C. Fiocchi, and A. D. Levine. 1998. Sequential and rapid activation of select caspases during apoptosis of normal intestinal epithelial cells. Am. J. Physiol. 274: G1117-G1124
56. Yeretssian, G., R. G. Correa, K. Doiron, P. Fitzgerald, C. P. Dillon, D. R. Green, J. C. Reed, and M. Saleh. 2011. Non-apoptotic role of BID in inflammation and innate immunity. Nature 474: 96-99
57. Fö rster, R., A. C. Davalos-Misslitz, and A. Rot. 2008. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8: 362-371
58. Ruemmele, F. M., S. Dionne, E. Levy, and E. G. Seidman. 1999. TNFalphainduced IEC-6 cell apoptosis requires activation of ICE caspases whereas complete inhibition of the caspa se cascade leads to necrotic cell death. Biochem. Biophys. Res. Commun. 260: 159-166
59. Burns, K., F. Martinon, and J. Tschopp. 2003. New insights into the mechanism of IL-1b maturation. Curr. Opin. Immunol. 15: 26-30
60. Blumberg, H., H. Dinh, E. S. Trueblood, J. Pretorius, D. Kugler, N. Weng, S. T. Kanaly, J. E. Towne, C. R. Willis, M. K. Kuechle, et al. 2007. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J. Exp. Med. 204: 2603-2614
61. Robertson, S. J., J. Y. Zhou, K. Geddes, S. J. Rubino, J. H. Cho, S. E. Girardin, and D. J. Philpott. 2013. Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis. Gut Microbes 4: 222-231
62. Idzko, M., H. Hammad, M. van Nimwegen, M. Kool, M. A. Willart, F. Muskens, H. C. Hoogsteden, W. Luttmann, D. Ferrari, F. Di Virgilio, et al. 2007. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. M ed. 13: 913-919
63. Riteau, N., P. Gasse, L. Fauconnier, A. Gombault, M. Couegnat, L. Fick, J. Kanellopoulos, V. F. Quesniaux, S. Marchand-Adam, B. Crestani, et al. 2010. Extra cellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 182: 774-783
64. Noguchi, T., K. Ishii, H. Fukutomi, I. Naguro, A. Matsuzawa, K. Takeda, and H. Ichijo. 2008. Requirement of reactive oxygen species-dependent activation of ASK1-p38 MAPK pathway for extracellular ATP-induced apoptosis in macrophage. J. Biol. Chem. 283: 7657-7665
65. Yilmaz, O., L. Yao, K. Maeda, T. M. Rose, E. L. Lewis, M. Duman, R. J. Lamont, and D. M. Ojcius. 2008. ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated hos t-cell apoptosis. Cell. Microbiol. 10: 863-875
66. Aswad, F., H. Kawamura, and G. Dennert. 2005. High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucle otide and ATP: a role for P2X7 receptors. J. Immunol. 175: 3075-3083
67. Ivanova, E. P., Y. V. Alexeeva, D. K. Pham, J. P. Wright, and D. V. Nicolau. 2006. ATP level variations in heterotrophic bacteria during attachment on hydrophilic and hydrophobic surfaces. Int. Microbiol. 9: 37-46.
68. Watanabe T.,A. Kitani,P.J. Murray,W. Strober, 2004, NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses, Nat. Immunol, 5, 800-808.
69. Watanabe, T., A. Kitani, P. J. Murray, Y. Wakatsuki, I. J. Fuss, and W. Strober. 2006. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 25: 473-485
70. van Heel, D. A., S. Ghosh, K. A. Hunt, C. G. Mathew, A. Forbes, D. P. Jewell, and R. J. Playford. 2005. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut 54: 1553-1557
71. Netea, M. G., G. Ferwerda, D. J. de Jong, T. Jansen, L. Jacobs, M. Kramer, T. H. Naber, J. P. Drenth, S. E. Girardin, B. J. Kullberg, et al. 2005. Nucleotidebinding oligomerization domain-2 modu lates specific TLR pathways for the induction of cytokine release. J. Immunol. 174: 6518-6523
72. Hedl, M., J. Li, J. H. Cho, and C. Abraham. 2007. Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc. Natl. Acad. Sci. USA 104: 19440-19445